These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

143 related articles for article (PubMed ID: 7497579)

  • 1. Evaluation of plasma 5-fluorouracil nucleoside levels in patients with metastatic breast cancer: relationships with toxicities.
    Barberi-Heyob M; Weber B; Merlin JL; Dittrich C; de Bruijn EA; Luporsi E; Guillemin F
    Cancer Chemother Pharmacol; 1995; 37(1-2):110-6. PubMed ID: 7497579
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Tumor-selective metabolism of 5-fluoro-2'-deoxycytidine coadministered with tetrahydrouridine compared to 5-fluorouracil in mice bearing Lewis lung carcinoma.
    Boothman DA; Briggle TV; Greer S
    Cancer Res; 1987 May; 47(9):2354-62. PubMed ID: 2952263
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Determination of 5-fluorouracil and its main metabolites in plasma by high-performance liquid chromatography: application to a pharmacokinetic study.
    Joulia JM; Pinguet F; Grosse PY; Astre C; Bressolle F
    J Chromatogr B Biomed Sci Appl; 1997 May; 692(2):427-35. PubMed ID: 9188833
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Plasma concentrations of 5-fluorouracil and its metabolites in colon cancer patients.
    Casale F; Canaparo R; Serpe L; Muntoni E; Pepa CD; Costa M; Mairone L; Zara GP; Fornari G; Eandi M
    Pharmacol Res; 2004 Aug; 50(2):173-9. PubMed ID: 15177306
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Pharmacokinetic analysis of doxifluridine and its metabolites, 5-fluorouracil and 5-fluorouridine, after oral administration in beagle dogs.
    Baek IH; Lee BY; Kim MS; Kwon KI
    Eur J Drug Metab Pharmacokinet; 2013 Dec; 38(4):295-9. PubMed ID: 23564503
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Phase I and pharmacologic evaluation of intraperitoneal 5-fluoro-2'-deoxyuridine.
    Muggia FM; Chan KK; Russell C; Colombo N; Speyer JL; Sehgal K; Jeffers S; Sorich J; Leichman L; Beller U
    Cancer Chemother Pharmacol; 1991; 28(4):241-50. PubMed ID: 1831736
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Modulation of 1-beta-D-arabinofuranosylcytosine metabolism and cytotoxicity in L1210 cells by fluoropyrimidine pretreatment.
    Grant S; Cadman E
    Cancer Res; 1982 Sep; 42(9):3550-6. PubMed ID: 6213294
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effects of pyrimidine nucleoside phosphorylase inhibitors on hepatic fluoropyrimidine elimination in the rat.
    LaCreta FP; Warren BS; Williams WM
    Cancer Res; 1989 May; 49(10):2567-73. PubMed ID: 2523758
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Selective activation of 5'-deoxy-5-fluorouridine by tumor cells as a basis for an improved therapeutic index.
    Armstrong RD; Diasio RB
    Cancer Res; 1981 Dec; 41(12 Pt 1):4891-4. PubMed ID: 6171343
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effect of guanosine on antitumor activity of fluorinated pyrimidines against P 388 leukemia.
    Iigo M; Hoshi A
    Cancer Chemother Pharmacol; 1984; 13(2):86-90. PubMed ID: 6235977
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Differences in activities and substrate specificity of human and murine pyrimidine nucleoside phosphorylases: implications for chemotherapy with 5-fluoropyrimidines.
    el Kouni MH; el Kouni MM; Naguib FN
    Cancer Res; 1993 Aug; 53(16):3687-93. PubMed ID: 8339277
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Correlation between ribosomal RNA production and RNA-directed fluoropyrimidine cytotoxicity.
    Takimoto CH; Tan YY; Cadman EC; Armstrong RD
    Biochem Pharmacol; 1987 Oct; 36(19):3243-8. PubMed ID: 2444230
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Different mechanisms of acquired resistance to fluorinated pyrimidines in human colorectal cancer cells.
    Murakami Y; Kazuno H; Emura T; Tsujimoto H; Suzuki N; Fukushima M
    Int J Oncol; 2000 Aug; 17(2):277-83. PubMed ID: 10891536
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Therapeutic efficacy of fluoropyrimidines depends on the duration of thymidylate synthase inhibition in the murine colon 26-B carcinoma tumor model.
    van Laar JA; van der Wilt CL; Rustum YM; Noordhuis P; Smid K; Pinedo HM; Peters GJ
    Clin Cancer Res; 1996 Aug; 2(8):1327-33. PubMed ID: 9816304
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Pharmacokinetics of 5-fluorouracil (5-FUra) in patients with metastatic colorectal cancer receiving 5-FUra bolus plus continuous infusion with high dose folinic acid (LV5FU2).
    Joulia JM; Pinguet F; Ychou M; Duffour J; Topart D; Grosse PY; Astre C; Bressolle F
    Anticancer Res; 1997; 17(4A):2727-30. PubMed ID: 9252705
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effect of administration of 5-(phenylselenenyl)acyclouridine, an inhibitor of uridine phosphorylase, on the anti-tumor efficacy of 5-fluoro-2'-deoxyuridine against murine colon tumor C26-10.
    Ashour OM; Naguib FN; Goudgaon NM; Schinazi RF; el Kouni MH
    Biochem Pharmacol; 2000 Sep; 60(5):687-92. PubMed ID: 10927027
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Gas-liquid chromatographic analysis of fluoropyrimidine nucleosides and fluorouracil in plasma and urine.
    Williams WM; Warren BS; Lin F
    Anal Biochem; 1985 Jun; 147(2):478-86. PubMed ID: 3160256
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Antitumor activity of the weekly intravenous push schedule of 5-fluoro-2'-deoxyuridine +/- N-phosphonacetyl-L-aspartate in mice bearing advanced colon carcinoma 26.
    van Laar JA; Durrani FA; Rustum YM
    Cancer Res; 1993 Apr; 53(7):1560-4. PubMed ID: 8453623
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Concentrations of the DNA methyltransferase inhibitor 5-fluoro-2'-deoxycytidine (FdCyd) and its cytotoxic metabolites in plasma of patients treated with FdCyd and tetrahydrouridine (THU).
    Beumer JH; Parise RA; Newman EM; Doroshow JH; Synold TW; Lenz HJ; Egorin MJ
    Cancer Chemother Pharmacol; 2008 Jul; 62(2):363-8. PubMed ID: 17899082
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Clinical pharmacological studies of concurrent infusion of 5-fluorouracil and thymidine in treatment of colorectal carcinomas.
    Au JL; Rustum YM; Ledesma EJ; Mittelman A; Creaven PJ
    Cancer Res; 1982 Jul; 42(7):2930-7. PubMed ID: 6211226
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.